Last Updated 00:00:00
longbridge loading
Company Encyclopedia
name
JZT
000989.SZ
Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment; Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong capsules for gynecological treatment; Houyan pills for ear, nose, and throat (ENT) diseases; Jianwei Yuyang tablets for digestion; and prescription drug product systems, Jiaxi Ganxian granules, and Chidan Tuihuang granules for liver diseases. The company also provides over-the-counter (OTC) drugs comprising blood-tonifying, cardiovascular and cerebrovascular, urinary system, pediatric, gynecologic, bone and muscles, respiratory system, dermatologic, nervous system, ENT, and digestive system products, and stem cell and other drugs.
2.788 T
000989.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
B
PharmaceuticalsIndustry
Industry Ranking37/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE7.01%C
    • Profit Margin11.31%B
    • Gross Margin60.59%A
  • Growth ScoreB
    • Revenue YoY14.27%B
    • Net Profit YoY44.04%B
    • Total Assets YoY6.38%B
    • Net Assets YoY5.50%C
  • Cash ScoreB
    • Cash Flow Margin179.14%B
    • OCF YoY14.27%B
  • Operating ScoreC
    • Turnover0.43C
  • Debt ScoreB
    • Gearing Ratio25.09%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --